HCPCS Level II drug code
J7324 — Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
In short
J7324 is the HCPCS Level II code for hyaluronan or derivative, orthovisc, for intra-articular injection, per dose. CMS assigns NDCs for Orthovisc to it. The Medicare Part B payment limit is $116.793 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
- Short descriptor
- Orthovisc inj per dose
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2008
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J7324
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 1 NDC to J7324 for Orthovisc. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Orthovisc | 59676-0360-01 | DePuy Synthes Sales, Inc. | 2 | 1 |
J7324: common questions
- Is J7324 a CPT code?
- No. J7324 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7324?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 1 NDC under J7324, for Orthovisc. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7324?
- $116.793 per per dose, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.